Menu
Annual · values202520242023202220212020201920182017201620152014
Operating Cash Flow42.81 M USD40.66 M USD35.85 M USD5.21 M USD2.63 M USD2.79 M USD2.51 M USD9.01 M USD4.19 M USD7.03 M USD2.40 M USD-991000 USD
Depreciation & Amortization6.64 M USD6.79 M USD6.54 M USD6.27 M USD3.68 M USD2.79 M USD3.54 M USD3.63 M USD1.85 M USD799000 USD827000 USD706000 USD
Stock-Based Compensation8.36 M USD7.82 M USD7.55 M USD9.60 M USD10.17 M USD10.69 M USD9.82 M USD7.97 M USD4.24 M USD1.89 M USD316000 USD148000 USD
Capital Expenditures2.38 M USD2.39 M USD2.32 M USD1.78 M USD2.10 M USD2.06 M USD5.45 M USD4.20 M USD3.75 M USD775000 USD592000 USD353000 USD
Cash Flow from Investing-2.54 M USD-2.50 M USD-2.48 M USD-1.91 M USD-82.18 M USD20.18 M USD-2.33 M USD-14.73 M USD-14.02 M USD-11.84 M USD-615000 USD-353000 USD
Cash Flow from Financing-51.20 M USD-4.82 M USD5.73 M USD-9.60 M USD59.93 M USD2.11 M USD2.50 M USD1.85 M USD3.09 M USD28.45 M USD-140000 USD221000 USD
Dividends Paid
Stock Buybacks26.56 M USD3.51 M USD493000 USD
Free Cash Flow40.43 M USD38.26 M USD33.53 M USD3.43 M USD528000 USD735000 USD-2.94 M USD4.81 M USD446000 USD6.26 M USD1.81 M USD-1.34 M USD

Tactile Systems Technology Inc. is a medical device company specializing in the development and marketing of therapeutic products for patients with chronic diseases. Its primary function is to produce and distribute advanced pneumatic compression devices aimed at treating chronic swelling conditions such as lymphedema and chronic venous insufficiency. These devices are designed to alleviate symptoms, improve patient mobility, and ultimately enhance quality of life. The company serves a range of healthcare sectors, including home healthcare providers, hospitals, and clinics, ensuring its products reach a wide array of patients who require this specialized form of care. Tactile Systems Technology Inc. plays a significant role in the healthcare market by focusing on non-invasive treatment options that can lead to more effective patient management solutions. Based in the United States, the company is recognized for its commitment to innovation and its contribution to the enhancement of healthcare delivery in chronic care management sectors.